Immutep

Soluble LAG-3

Immutep S.A. announced today the publication of a research paper showing that a soluble human LAG-3 protein amplifies the in vitro generation of type 1 tumor-specific immunity.

The study (Cancer Research 2006; 66: (8): 4450-60) was carried out by Chiara Castelli and coworkers in Pr. Giorgio Parmiani's group of Italy's National Tumor Institute in Milan. This group has belonged to the top tier of European tumor immunology groups for more than 20 years, in terms of both basic and clinical research activities.

Click to read the complete Press Release (PDF Format).


Published 05/2006 by admin@immutep.com